Fermentation Engineering for Pharmaceutical Drugs - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB505240523

Publication Date:

May 2, 2024

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Fermentation is a process used for cultivating micro-organisms or other organic material into important pharmaceuticals such as antibiotics, therapeutic proteins, enzymes and insulin. It is typically carried out in temperature-controlled tanks (fermenter) which require addition of nutrients at the correct concentration to maximize productivity of the organism of interest.
The global market for Fermentation Engineering for Pharmaceutical Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
In China, 5 largest manufacturers of Fermentation Engineering for Pharmaceutical Drugs are Changchun GeneScience Pharmaceutical, 3SBio Inc, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical and Shanghai Shyndec Pharmaceutical, which make up over 15%. Among them, Changchun GeneScience Pharmaceutical is the leader with about 6% market share. In terms of product type, Monoclonal Antibodies occupy the largest share of the total market, about 54%. And in terms of product Application, the largest application is Hospital, followed by Clinic.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fermentation Engineering for Pharmaceutical Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Fermentation Engineering for Pharmaceutical Drugs by region & country, by Type, and by Application.
The Fermentation Engineering for Pharmaceutical Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fermentation Engineering for Pharmaceutical Drugs.
麻豆原创 Segmentation
By Company
Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group
Segment by Type:
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fermentation Engineering for Pharmaceutical Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Fermentation Engineering for Pharmaceutical Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Fermentation Engineering for Pharmaceutical Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Fermentation Engineering for Pharmaceutical Drugs Product Introduction
1.2 Global Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Size Forecast
1.3 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Trends & Drivers
1.3.1 Fermentation Engineering for Pharmaceutical Drugs Industry Trends
1.3.2 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Drivers & Opportunity
1.3.3 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Challenges
1.3.4 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fermentation Engineering for Pharmaceutical Drugs Players Revenue Ranking (2023)
2.2 Global Fermentation Engineering for Pharmaceutical Drugs Revenue by Company (2019-2024)
2.3 Key Companies Fermentation Engineering for Pharmaceutical Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Fermentation Engineering for Pharmaceutical Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Fermentation Engineering for Pharmaceutical Drugs
2.6 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Competitive Analysis
2.6.1 Fermentation Engineering for Pharmaceutical Drugs 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Fermentation Engineering for Pharmaceutical Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fermentation Engineering for Pharmaceutical Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monoclonal Antibodies
3.1.2 Antibiotic
3.1.3 Insulin
3.1.4 Human Growth Hormone
3.1.5 Pharmaceutical Amino Acids
3.1.6 Others
3.2 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type
3.2.1 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application
4.2.1 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Region
5.1.1 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Region (2019-2024)
5.1.3 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Region (2025-2030)
5.1.4 Global Fermentation Engineering for Pharmaceutical Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
5.2.2 North America Fermentation Engineering for Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
5.3.2 Europe Fermentation Engineering for Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Fermentation Engineering for Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
5.5.2 South America Fermentation Engineering for Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fermentation Engineering for Pharmaceutical Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Fermentation Engineering for Pharmaceutical Drugs Sales Value
6.3 United States
6.3.1 United States Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
6.3.2 United States Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
6.4.2 Europe Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
6.5.2 China Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
6.6.2 Japan Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
6.7.2 South Korea Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Fermentation Engineering for Pharmaceutical Drugs Sales Value, 2019-2030
6.9.2 India Fermentation Engineering for Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Fermentation Engineering for Pharmaceutical Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Changchun GeneScience Pharmaceutical
7.1.1 Changchun GeneScience Pharmaceutical Profile
7.1.2 Changchun GeneScience Pharmaceutical Main Business
7.1.3 Changchun GeneScience Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.1.4 Changchun GeneScience Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 Changchun GeneScience Pharmaceutical Recent Developments
7.2 3SBio Inc
7.2.1 3SBio Inc Profile
7.2.2 3SBio Inc Main Business
7.2.3 3SBio Inc Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.2.4 3SBio Inc Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 3SBio Inc Recent Developments
7.3 Shanghai Fosun Pharmaceutical
7.3.1 Shanghai Fosun Pharmaceutical Profile
7.3.2 Shanghai Fosun Pharmaceutical Main Business
7.3.3 Shanghai Fosun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.3.4 Shanghai Fosun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Sichuan Kelun Pharmaceutical Recent Developments
7.4 Sichuan Kelun Pharmaceutical
7.4.1 Sichuan Kelun Pharmaceutical Profile
7.4.2 Sichuan Kelun Pharmaceutical Main Business
7.4.3 Sichuan Kelun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.4.4 Sichuan Kelun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Sichuan Kelun Pharmaceutical Recent Developments
7.5 Shanghai Shyndec Pharmaceutical
7.5.1 Shanghai Shyndec Pharmaceutical Profile
7.5.2 Shanghai Shyndec Pharmaceutical Main Business
7.5.3 Shanghai Shyndec Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.5.4 Shanghai Shyndec Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Shanghai Shyndec Pharmaceutical Recent Developments
7.6 CSPC Pharmaceutical Group
7.6.1 CSPC Pharmaceutical Group Profile
7.6.2 CSPC Pharmaceutical Group Main Business
7.6.3 CSPC Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.6.4 CSPC Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 CSPC Pharmaceutical Group Recent Developments
7.7 United Laboratories International Holdings
7.7.1 United Laboratories International Holdings Profile
7.7.2 United Laboratories International Holdings Main Business
7.7.3 United Laboratories International Holdings Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.7.4 United Laboratories International Holdings Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.7.5 United Laboratories International Holdings Recent Developments
7.8 Tonghua Dongbao Pharmaceutical
7.8.1 Tonghua Dongbao Pharmaceutical Profile
7.8.2 Tonghua Dongbao Pharmaceutical Main Business
7.8.3 Tonghua Dongbao Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.8.4 Tonghua Dongbao Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.8.5 Tonghua Dongbao Pharmaceutical Recent Developments
7.9 Joincare Pharmaceutical Group
7.9.1 Joincare Pharmaceutical Group Profile
7.9.2 Joincare Pharmaceutical Group Main Business
7.9.3 Joincare Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.9.4 Joincare Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.9.5 Joincare Pharmaceutical Group Recent Developments
7.10 North China Pharma
7.10.1 North China Pharma Profile
7.10.2 North China Pharma Main Business
7.10.3 North China Pharma Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.10.4 North China Pharma Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.10.5 North China Pharma Recent Developments
7.11 Anhui Anke Biotechnology
7.11.1 Anhui Anke Biotechnology Profile
7.11.2 Anhui Anke Biotechnology Main Business
7.11.3 Anhui Anke Biotechnology Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.11.4 Anhui Anke Biotechnology Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.11.5 Anhui Anke Biotechnology Recent Developments
7.12 Gan and Lee Pharmaceuticals
7.12.1 Gan and Lee Pharmaceuticals Profile
7.12.2 Gan and Lee Pharmaceuticals Main Business
7.12.3 Gan and Lee Pharmaceuticals Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.12.4 Gan and Lee Pharmaceuticals Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.12.5 Gan and Lee Pharmaceuticals Recent Developments
7.13 Shandong Kexing Bioproducts
7.13.1 Shandong Kexing Bioproducts Profile
7.13.2 Shandong Kexing Bioproducts Main Business
7.13.3 Shandong Kexing Bioproducts Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.13.4 Shandong Kexing Bioproducts Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.13.5 Shandong Kexing Bioproducts Recent Developments
7.14 Harbin Pharmaceutical Group
7.14.1 Harbin Pharmaceutical Group Profile
7.14.2 Harbin Pharmaceutical Group Main Business
7.14.3 Harbin Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Products, Services and Solutions
7.14.4 Harbin Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Revenue (US$ Million) & (2019-2024)
7.14.5 Harbin Pharmaceutical Group Recent Developments
8 Industry Chain Analysis
8.1 Fermentation Engineering for Pharmaceutical Drugs Industrial Chain
8.2 Fermentation Engineering for Pharmaceutical Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fermentation Engineering for Pharmaceutical Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Fermentation Engineering for Pharmaceutical Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.